Wang-Zwische Double Lumen Cannula—Toward a Percutaneous and Ambulatory Paracorporeal Artificial Lung

Department of Surgery, University of Kentucky College of Medicine, Lexington, Kentucky, USA.
ASAIO journal (American Society for Artificial Internal Organs: 1992) (Impact Factor: 1.52). 11/2008; 54(6):606-11. DOI: 10.1097/MAT.0b013e31818c69ab
Source: PubMed


We are developing a high performance double lumen cannula (DLC) for a minimally invasive, ambulatory and percutaneous paracorporeal artificial lung (PAL). The Wang-Zwische (W-Z) DLC was designed for percutaneous insertion into the Internal Jugular (IJ) vein with a drainage lumen open to both the superior vena cava (SVC) and the inferior vena cava (IVC) maximizing venous drainage. A separate collapsible but nondistensible membrane infusion lumen open to the right atrium (RA) achieves minimal recirculation allowing for total gas exchange. The W-Z DLC prototypes are made by a proprietary dip molding process with the "molded in" flat wire spiral stainless steel spring resulting in a flexible yet kink resistant thin wall (0.1 mm) outer cannula with one piece construction. With the ultra thin membrane infusion lumen collapsed, an introducer shaft fits tightly within the drainage lumen to facilitate insertion with placement at the SVC-RA-IVC junction. The W-Z DLC prototypes were tested while connected to a compact pump-gas exchanger circuit in three sheep (2 acute and one 15 day performance study). Insertion was simple, using standard percutaneous insertion techniques. Recirculation was as low as 2%. The 15 day performance study demonstrated our prototype 26 Fr W-Z DLC can achieve 2 L/min blood flow with minimal recirculation. The W-Z DLC design minimizes recirculation rate, maximizes flow lumen cross-sectional area, and maximizes achievable blood flow to enhance gas exchange performance allowing for one site percutaneous venovenous support.

Download full-text


Available from: Dongfang Wang, Sep 15, 2014
  • Source
    • "Patients receiving venovenous or venoarterial ECMO have traditionally been considered too unstable for active physical therapy, frequently are heavily sedated, and occasionally are administered neuromuscular blocking agents. However, the ability to ambulate while receiving ECMO support has been facilitated by advances in extracorporeal technology and cannulation techniques [14-17]. Additionally, mobilization may be facilitated when ECMO allows for weaning from invasive mechanical ventilation [18]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Critical illness is a well-recognized cause of neuromuscular weakness and impaired physical functioning. Physical therapy (PT) has been demonstrated to be safe and effective for critically ill patients. The impact of such an intervention on patients receiving extracorporeal membrane oxygenation (ECMO) has not been well characterized. We describe the feasibility and impact of active PT on ECMO patients. We performed a retrospective cohort study of 100 consecutive patients receiving ECMO in the medical intensive care unit of a university hospital. Of the 100 patients receiving ECMO, 35 (35%) participated in active PT; 19 as bridge to transplant and 16 as bridge to recovery. Duration of ECMO was 14.3 +/- 10.9 days. Patients received 7.2 +/- 6.5 PT sessions while on ECMO. During PT sessions, 18 patients (51%) ambulated (median distance 175 feet, range 4 to 2800) and 9 patients were on vasopressors. Whilst receiving ECMO, 23 patients were liberated from invasive mechanical ventilation. Of the 16 bridge to recovery patients, 14 (88%) survived to discharge; 10 bridge to transplant patients (53%) survived to transplantation, with 9 (90%) surviving to discharge. Of the 23 survivors, 13 (57%) went directly home, 8 (35%) went to acute rehabilitation, and 2 (9%) went to subacute rehabilitation. There were no PT-related complications. Active PT, including ambulation, can be achieved safely and reliably in ECMO patients when an experienced, multidisciplinary team is utilized. More research is needed to define the barriers to PT and the impact on survival and long-term functional, neurocognitive outcomes in this population.
    Critical care (London, England) 02/2014; 18(1):R38. DOI:10.1186/cc13746 · 4.48 Impact Factor
  • Source
    • "Heparin-coated wire-reinforced cannulae may be placed percutaneously in a femoral–femoral or a femoral–jugular orientation. Alternatively, a wire-reinforced double-lumen catheter may be inserted under ultrasound guidance via the right internal jugular vein with the drainage port positioned in the intra-hepatic inferior vena cava and the return port in the right atrium [21,26]. A flow of fresh gas containing little or no CO2 is utilised to create a diffusion gradient across the membrane and allows CO2 removal. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Evolution of extracorporeal life support (ECLS) technology has added a new dimension to the intensive care management of acute cardiac and /or respiratory failure in adult patients who fail conventional treatment. ECLS also effectively compliments cardiac surgery, high risk interventional cardiology, long-term mechanical cardiac assist device, heart and lung transplantation programmes. Available ECLS therapies provide a range of options to the multidisciplinary teams who are involved in the time critical care of these complex patients. While venovenous extracorporeal membrane oxygenation (ECMO) can provide complete respiratory support, extracorporeal carbon dioxide removal facilitates protective lung ventilation and provides only partial respiratory support. Mechanical circulatory support (MCS) with venoarterial (VA) ECMO employed in a traditional peripheral/central fashion or in temporary ventricular assist device (VAD) configuration may stabilise patients with decompensated cardiac failure who have evidence of end organ dysfunction, allowing time for recovery, decision making, bridging to implantation of a long-term MCS device and heart or lung transplantation. In highly selected patients with combined severe cardiac and respiratory failure, advanced ECLS can be provided with central VA ECMO or by addition of an oxygenator in the temporary VAD circuits to allow time for restitution of physiology and decision making. This article summarises the available ECLS options and provides insights into the principles and practice of these techniques. It should be emphasised that, as is common with many emerging therapies, their optimal use is currently not backed by quality evidence. This deficiency needs to be addressed to ensure the full potential of ECLS can be realised.
    Critical Care 01/2014; 18(3). DOI:10.1186/cc13865 · 4.48 Impact Factor
  • Source
    • "ECMO was initiated as BTT. A bicaval dual-lumen cannula, designed to drain deoxygenated blood from the vena cavae and reinfuse oxygenated blood across the tricuspid valve, was inserted via the right internal jugular vein (RIJV; Table 2).[1213] By directing reinfused blood across the ASD toward the left atrium, an oxygenated right-to-left shunt was created, effectively providing venoarterial ECMO with a single venous access site.[14] "
    [Show abstract] [Hide abstract]
    ABSTRACT: Pulmonary arterial hypertension (PAH) is a disease with significant morbidity and mortality, particularly during an acute decompensation. We describe a single-center experience of three patients with severe Group 1 PAH, refractory to targeted medical therapy, in which an extubated, nonsedated, extracorporeal membrane oxygenation (ECMO) strategy with an upper-body configuration was used as a bridge to recovery or lung transplantation. All three patients were extubated within 24 hours of ECMO initiation. Two patients were successfully bridged to lung transplantation, and the other patient was optimized on targeted PAH therapy with subsequent recovery from an acute decompensation. The upper-body ECMO configuration allowed for daily physical therapy, including one patient, who would otherwise have been unsuitable for transplantation, ambulating over 850 meters daily. This series demonstrates the feasibility of using ECMO to bridge PAH patients to recovery or transplantation while avoiding the complications of immobility and invasive mechanical ventilation.
    04/2013; 3(2):432-5. DOI:10.4103/2045-8932.113178
Show more